Convatec Share Discussion Threads

[hazl] 26/7/2018 07:38

worth a read.imo

[hazl] 26/7/2018 07:38

Whilst looking back through the posts I liked your post 188 robow.

[hazl] 25/7/2018 19:46

OLDER but relevant IMO

[hazl] 25/7/2018 14:16

That's the way to do it!

[hazl] 25/7/2018 12:11

Well a merry dance this morning but looks as though it wants to turn up.

IMO

[hazl] 25/7/2018 08:39

Well Morgan Stanley know what they're doing.....

on the 19th of the seventh....bought


shares


5.01% 1,961,473,904 !

[hazl] 25/7/2018 07:47

I think there is the need for a different thread.
Psychologically the header might put people off!

[hazl] 25/7/2018 07:31

THE American interest holds the promise....

imo

[hazl] 25/7/2018 06:44

LET'S see if this is the start of a new and exciting financial stage!

[douglas fir] 24/7/2018 16:55

ps..interesting volume+movement on ztf...

[douglas fir] 24/7/2018 16:54

..indeed..

[hazl] 24/7/2018 16:28

a good start....

[hazl] 24/7/2018 13:32

Ah, there was a problem described by the FT in February this year,that they thought would affect first half but improve by second half of the year.
Hurricanes in the DOMINICAN REPUBLIC...where they make some of their products,held them back.

I think it looks like this is not only in recovery but attracting interest,not only in it's products,but as robow points out,investors....worthy investors!

IMO

[hazl] 24/7/2018 13:19

Perhaps there will be more reports out now on them after this good news.
I found this one from back in February where they thought they were a good buy then by the looks of it.

'Buy Convatec for recovery, says Share Centre

Strong full-year results from medical technology company Convatec (CTEC) boosted the shares but they are still a ‘long way’ from their highs and remain a buying opportunity, believes The Share Centre.

Analyst Helal Miah retained his ‘buy’ recommendation for ‘investors seeking a recovery potential and willing to accept a higher level of risk’ following last week’s results saw the shares rally 7%. They dipped 1%, or 2.3p, to 213p on Monday.

‘Overall the group has shown some positive progress, it operates in a defensive market with significant growth opportunities,’; said Miah.

‘While the shares are a long way off from its highs, we believe this is a growth opportunity to pick up these shares for the long term.’

He added that the underlying market for Convatec is ‘defensive in nature, but growth opportunities exist from ageing populations, the increased prevalence of chronic conditions, and the fact that patients are living longer with these conditions’

[robow] 24/7/2018 13:09

Morgan Stanley timed their increase well

[hazl] 24/7/2018 12:26

;'Commercial availability in the U.S. is expected to commence alongside product evaluations in October'.



I like the word 'commercial.'

[hazl] 24/7/2018 12:12

WORTH REPEATING IMO

[hazl] 24/7/2018 12:11

'24 July 2018

ConvaTec Receives U.S. FDA 510(k) Clearance for its most advanced and innovative antimicrobial dressing: AQUACEL(TM) Ag Advantage dressing

-- Developed to help clinicians reduce the significant burden of chronic, non-healing wounds

-- Unique Advantage formulation provides enhanced antimicrobial performance[1] in combination with Hydrofiber(TM) Technology

READING, UNITED KINGDOM (24 July 2018) - ConvaTec Group Plc ("ConvaTec"), a leading global medical products and technologies company, today announced it received U.S. Food and Drug Administration (FDA) 510(k) clearance for its AQUACEL(TM) Ag Advantage* dressing for wound management.

In clinical studies and global practice, ConvaTec's proven, advanced antimicrobial dressing has demonstrated substantial wound improvements even in the most hard-to-heal wounds[2](,[3]) , and in 2016 was recognized by international wound care experts for its innovative and breakthrough technology with the ability to change patient lives.

Chronic non-healing wounds have a significant impact on quality of life for patients, many of whom are elderly, have diabetes or other underlying conditions, which often lead to serious events such as limb amputations or premature death.[4] In the U.S. Medicare recently published data showed that 8.2 million seniors had at least one type of wound or wound-related infection, with an estimated annual cost of up to $96.8 billion.[5]

"Delayed wound healing presents multiple challenges for clinicians, and places a heavy burden on patients, society and our healthcare systems. Moving these types of recalcitrant wounds from a deteriorating or stagnant state toward improvement requires novel, non-antibiotic strategies," said Randall Wolcott, MD, Medical Director, Southwest Regional Wound Care Center, Lubbock, Texas. "I'm very excited about this new innovative dressing, which has shown significant potential to address this burden while not driving antibiotic resistance."

"AQUACEL Ag Advantage dressing is the culmination of many years of research and collaboration with clinicians to more effectively address their most difficult and persistent challenges in wound management," added Fiona Adam, Interim President, Advanced Wound Care, ConvaTec. "Customer feedback in markets outside the U.S. has been very positive, and we look forward to introducing U.S. clinicians to the latest addition to our AQUACEL family, and continuing to help wound specialists around the world promote better healing outcomes, address further unmet needs in wound care, and help more patients resume their daily lives."

"In clinical evaluation studies, we have seen excellent results in chronic non-healing wounds, some of which have not healed in years despite the use of topical antimicrobials and systemic antibiotics. We've also heard from many clinicians who have said the use of the new dressing has helped them save patients' limbs and lives."

AQUACEL Ag Advantage dressing is currently available in markets across Europe and Asia Pacific, where it is marketed as AQUACEL Ag+ Extra dressing. Commercial availability in the U.S. is expected to commence alongside product evaluations in October. '

[hazl] 24/7/2018 09:30

getting exciting now....

[hazl] 24/7/2018 08:58

Very good spread at least.

[hazl] 24/7/2018 08:25

Oh and dividends once a year....

[hazl] 24/7/2018 08:25

How many companies like this do you know, that are actually bringing in earnings?

[hazl] 24/7/2018 07:48

Fundamentals are impressive AND they help people.

[hazl] 24/7/2018 07:38

Morgan Stanley over 5% yesterday,....